Venetoclax for arsenic-resistant acute promyelocytic leukaemia

被引：16

作者：

Wang, Qian Qian ^{[1
]}

Wang, Hua-Feng ^{[1
,2
,3
]}

Zhao, Jian-Zhi ^{[4
]}

Naranmandura, Hua ^{[1
]}

Jin, Jie ^{[1
,2
,3
]}

Zhu, Hong-Hu ^{[1
,2
,3
,5
,6
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Haematol, Hangzhou, Zhejiang, Peoples R China

[2] Zhejiang Univ, Zhejiang Prov Key Lab Haematol Oncol Diag & Trea, Hangzhou, Peoples R China

[3] Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China

[4] Shaoxing Cent Hosp, Dept Haematol, Shaoxing, Peoples R China

[5] Zhejiang Univ, Med Ctr, Zhejiang Lab Syst & Precis Med, Hangzhou, Peoples R China

[6] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou, Peoples R China

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 197卷 / 05期

关键词：

acute promyelocytic leukaemia; all-trans retinoic acid; arsenic; mutation; venetoclax;

D O I：

10.1111/bjh.18061

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E58 / E60

页数：3

共 5 条

[1] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].

DiNardo, C. D. ;

Jonas, B. A. ;

Pullarkat, V. ;

Thirman, M. J. ;

Garcia, J. S. ;

Wei, A. H. ;

Konopleva, M. ;

Doehner, H. ;

Letai, A. ;

Fenaux, P. ;

Koller, E. ;

Havelange, V. ;

Leber, B. ;

Esteve, J. ;

Wang, J. ;

Pejsa, V. ;

Hajek, R. ;

Porkka, K. ;

Illes, A. ;

Lavie, D. ;

Lemoli, R. M. ;

Yamamoto, K. ;

Yoon, S. -S. ;

Jang, J. -H. ;

Yeh, S. -P. ;

Turgut, M. ;

Hong, W. -J. ;

Zhou, Y. ;

Potluri, J. ;

Pratz, K. W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629

[2] Varying responses of PML-RARA with different genetic mutations to arsenic trioxide [J].

Liu, Jiangying ;

Zhu, Hong-Hu ;

Jiang, Hao ;

Jiang, Qian ;

Huang, Xiao-Jun .

BLOOD, 2016, 127 (02) :243-250

[3] Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia [J].

Lo-Coco, F. ;

Avvisati, G. ;

Vignetti, M. ;

Thiede, C. ;

Orlando, S. M. ;

Iacobelli, S. ;

Ferrara, F. ;

Fazi, P. ;

Cicconi, L. ;

Di Bona, E. ;

Specchia, G. ;

Sica, S. ;

Divona, M. ;

Levis, A. ;

Fiedler, W. ;

Cerqui, E. ;

Breccia, M. ;

Fioritoni, G. ;

Salih, H. R. ;

Cazzola, M. ;

Melillo, L. ;

Carella, A. M. ;

Brandts, C. H. ;

Morra, E. ;

von Lilienfeld-Toal, M. ;

Hertenstein, B. ;

Wattad, M. ;

Luebbert, M. ;

Haenel, M. ;

Schmitz, N. ;

Link, H. ;

Kropp, M. G. ;

Rambaldi, A. ;

La Nasa, G. ;

Luppi, M. ;

Ciceri, F. ;

Finizio, O. ;

Venditti, A. ;

Fabbiano, F. ;

Doehner, K. ;

Sauer, M. ;

Ganser, A. ;

Amadori, S. ;

Mandelli, F. ;

Doehner, H. ;

Ehninger, G. ;

Schlenk, R. F. ;

Platzbecker, U. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :111-121

[4] Acute myeloid leukemia cells harboring MLL fusion genes or with the acute promyelocytic leukemia phenotype are sensitive to the Bcl-2-selective inhibitor ABT-199 [J].

Niu, X. ;

Wang, G. ;

Wang, Y. ;

Caldwel, J. T. ;

Edwards, H. ;

Xie, C. ;

Taub, J. W. ;

Li, C. ;

Lin, H. ;

Ge, Y. .

LEUKEMIA, 2014, 28 (07) :1557-1560

[5] Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia [J].

Zhu, Hong-Hu ;

Qin, Ya-Zhen ;

Huang, Xiao-Jun .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19) :1864-1866

← 1 →